Skip to main content

Full text of "Silver as a Cure for Ebola - Literature Collection"

See other formats


International Journal of Microbiological Research 1 (1 ): 33-36, 201 0 

ISSN 2079-2093 

© IDOSI Publications, 2010 

Colloidal Silver as a New Antimicrobial Agent 

Nouran H. Assar and HayamM. Hamuoda 

Department of Microbiology, 
National Organization for Drug Control and Research (NTODCER), Giza, Egypt 



Abstract: Silver has the advantage of having broad antimicrobial activities against Gram-negative and 
Gram-positive bacteria. This research was the result of bioassay experimentation on the effects of colloidal silver 
on multidrug resistant bacteria. The initial idea was to determine the antimicrobial activity of colloidal silver. 
So it could be used as a powerful in-vitro antimicrobial agent. Antimicrobial activity was determined by means 
of agar diffusion. Resistant clinical isolates of Staphylococcus aureus, Escherichia coli, pseudomonas 
aregnosa and Salmonella typhi were used as the test organisms. It was concluded this study showed 
successful formation of colloidal silver and their antibacterial activity against all tested pathogens. 



Key words: Antimicrobial activity • Silver • Bacteria 



INTRODUCTION 

The emergence and spread of antibiotic resistance 
is an alarming concern in clinical practice. Increasingly, 
agents with 'antimicrobial' effects are being coated on 
materials and medical devices [1] as a prophylaxis to 
prevent bacteria from growing or for therapeutic use. 
The new technology of impregnation of silver 
nanoparticles [2] is enabling a wider range of these 
medical products to be available to clinicians. The use 
of metallic silver as an antimicrobial agent has long been 
recognized [3, 4]. Dilute solutions of silver nitrate had 
been used since the 19 th century to treat infections and 
burns before the introduction of silver sulphadiazine 
cream [5]. 

Silver has the advantage of having broad 
antimicrobial activities against Gram-negative and 
Gram-positive bacteria and there is also minimal 
development of bacterial resistance [6]. 

The antimicrobial activity of silver has been 
recognized by clinicians for over 100 years [4]. In addition, 
many reports suggested that hygienic benefits have been 
associated with the use of silver for considerably longer 
time. In the same time, records showed that Hippocrates 
recognized the role of silver in the prevention of disease 
and the Romans stored wine in silver vessels to prevent 
spoilage. However, only in the last few decades the 
mode of action of silver as an antimicrobial agent has 
been studied without any rigour [7]. Silver nano-particles 



have also been demonstrated to exhibit antimicrobial 
properties both against bacteria [8] and viruses [9] with 
close attachment of the nano-particles themselves with 
the microbial cells / virus particles being demonstrated 
with activity being size dependent [9]. Despite this, the 
principle activity of silver is as results of the production 
of silver ions within an aqueous matrix [10]. This therefore 
implies that for silver to have an antimicrobial effect, 
free water must be present. Interruption of cell wall 
synthesis resulting in loss of essential nutrients has 
been shown to occur in yeasts [11] and may well occur in 
other fungi. Antiviral activity of silver ions has been 
recorded and interaction with -SH groups has been 
implicated in the mode of action. The association of silver 
nano-particles with the envelope of certain viruses has 
been suggested to prevent them from being infective [9]. 

The current work was designed to throw lights on 
the in vitro antibacterial activity of colloidal silver with 
special emphasis on the comparison between silver 
solutions, sulphonamides and trimethoprime alone or in 
combination. 

MATERIALS AND METHODS 

Preparation of the Colloidal Silver Suspension in Pure 
Water: Colloidal silver solution was electrically prepared. 
Pure silver wires were used as both the positive and 
negative electrodes. The pure silver wires were etched by 
the DC pulse arc-discharge in pure water [1 2]. 



Corresponding Author: Nouran H. Assar, Department of Microbiology, 

National Organization for Drug Control and Research (NODCER), Giza, Egypt 

33 



Intl. J. Microbiol. Res., 1 (1): 33-36, 2010 



Determination of Antibiotics Susceptibility (By Disc 
Diffusion Method): The tested isolates were sub cultured 
on nutrient agar plates for 24 hours at 37°C. 3-4 similar 
colonies were selected and aseptically transferred into 
5ml of Muller Hinton broth and incubated at 37°C for 
4-5 hours. One ml of the previous suspension was 
transferred to Muller Hinton agar tube and 
homogeneously suspend using vortex then the mixture 
was poured in a Petri dish and kept to dry for 1 0 minutes. 
Antibiotic discs were applied using aseptic technique 
with 1cm apart with gentle pressure to allow complete 
diffusion. 

The Antibiotic Discs Were Supplied from Oxoide 
Company: 

Chloroamphinicol © 30mcg 
Cefaclor (Cj) 30mcg 
Cefadroxil (Cfr) 
Ciprofloxacin (Cf) 5mcg 
Erythromycin (E) 1 5mcg 
Levofloxacin (Le) 5mcg 
Norfloxacin (Nx) 1 Omcg 

Sulphonamides&Trimethoprime (Stx) 23.75/1 .25mcg 
Tobramycin (Tb) 1 Qmcg 
Incubate plates 24 hours at 37°C. 



The diameter of the inhibition zones were measured 
and compared to a reference table to differentiate the 
isolates into sensitive, intermediate or resistant [13]. 
As shown in Table 1 . 

RESULTS 

Antimicrobial susceptibility test for different 
antibiotic groups and sliver solution against four isolates 
were determined using diffusion method (Table 1). 

Table 2 shows that all tested bacteria were resistant 
to more than one antibiotic. The important observation 
was the antibacterial activity of colloidal silver against 
Escherichia coli, Staphylococcus aureus, Salmonella 
typhi and Pseudomonas aeruginosa which exhibit 
superior effect compared with other antibiotics. 

Figure 1 Showed the antimicrobial susceptibility test 
for the different used antibiotic groups and sliver against 
four isolates. 

DISCUSSION 

The emergence and spread of antibiotic resistance is 
an alarming concern in clinical practice, Nanotechnology 
is gaining tremendous impetus in the present century due 
to its capability of modulating metals into their nanosize, 



Table 1 Zone diameter interpretation charts forthe antibiotics used according to NCCL2007 



Diameter of zone of inhibition in mm 



Antibiotic Class 



Antibiotic Name 



Symbol 



Disc content 



Resistant mm or less < 



Intermediate mm (I) Sensitive mm or more (S) 



Amphenicols 
Aminoglycosides 
Betalactams 
cephalosporins 

Sulphon amides & Trimethoprime 

Macrohdes 

Quinolones 



Chloroamphenicol C 30 meg 

Tobramycin Tb 10 meg 

Cefaclor Cj 30 meg 

cefadroxil Cfr 30 meg 

Sulphonamides & Trimethoprime Stx 23 75/1 25 meg 

Erythromycin E 15 meg 

Cibrofloxacin Cf 5 meg 

Levofloxacin Le 5 meg 

Norfloxacin Nx 10 meg 



13-17 

13- 14 
15-17 

15- 17 
11-15 

14- 22 

16- 20 
16-18 
13-16 



Table 2: Antimicrobial susceptibility test for different antibiotic group and sliver against four isolates 



Diameter of zone of inhibition in mm of resistant Bacterial isolates 



Antibiotic Name & 


taphylococcus aureus 


Pseudomonus aregnosa 


Salmonella 


yphi 


Echerishia coli 


Chi oro amph eni c ol 


I 


R 


R 




I 


Tobramycin 


R 


S 


I 




R 


Cefaclor 


R 


R 


R 




R 


cefadroxil 


R 


R 


R 




R 


Sulphonamides & Trimethoprime 


I 


R 


R 




R 


Erythromycin 


R 


R 


R 




R 


Cibrofloxacin 


R 


S 


R 




R 


Levofloxacin 


R 


S 


R 




R 


Norfloxacin 


R 


s 


R 




R 


Silver 


S 


s 


S 




S 



34 



Ml J. Microbiol. Res., I (1): 33-36, 2010 




Fig. 1: Antimicrobial susceptibility test for the different used antibiotic groups and sliver against four isolates 



which drastically changes the chemical, physical and 
optical properties of metals. Metallic silver in the form of 
silver nanopar tides has made a remarkable comeback as 
a potential antimicrobial agent. 

The present study showed successful formation of 
colloidal silver and their antibacterial activity against 
Escherichia coli (E. coli), Staphylococcus aureus 
(S. aureus), Salmonella typhi (S. typhi) and 
Pseudomonas aeruginosa (P. aeruginosa). Colloidal 
silver showed a strong bactericidal effect against E. coli y 
S. aureus and P. aeruginosa, these resuls were in 
agreement with those reported by Bryaskova et ai. [14]. 

In the present experiment, colloidal silver showed 
highly potent antibacterial activity toward both Gram- 
positive and Gram- negative bacteria. This condition may 
be due to its accumulation in the bacterial membrane. 
A membrane with such morphology exhibits a significant 
increase in permeability , resulting in death of the cell. 
Meanwhile, studies have demonstrated that silver ions 
interact with sulfhydryl (-SH) groups of proteins as well 
as the bases of DNA leading either to the inhibition of 
respiratory processes [15] or DNA unwinding [16]. 
Inhibition of cell division and damage to bacterial 
cell envelopes was also recorded [17] and interaction 
with hydrogen bonding processes has been also, 
demonstrated to occur [18]. However, the mechanism 



depends on both the concentration of silver ions present 
and the sensitivity of the microbial species to silver. In the 
same time, it was reported that contact time, temperature, 
pH and the presence of free water have clear impact on 
both the rate and extent of antimicrobial activity [19]. 
However, in the present study the spectrum of activity 
was very wide and the development of resistance was 
not recorded. Silver ions clearly do not possess a single 
mode of action. They interact with a wide range of 
molecular processes within microorganisms resulting in 
a range of effects from inhibition of growth, loss of 
infectivity to cell death. Another theory explained that 
colloidal silver works as a catalyst which can disable the 
enzymes that all unicellular bacteria, fungi and viruses use 
for their oxygen metabolism. Unlike with antibiotics, 
resistant strains have never been known to develop 
tell now. 

These nontoxic nanomaterials, which can be prepared 
in a simple and cost-effective manner, may be suitable for 
the formulation of new types of bactericidal materials and 
may be solve the problem of the emergence and spread of 
in vitro antibiotic resistance. 

Nan o silver could be electrically prepared with 
low cost, to be applied for external uses only, not for 
systemic application and further investigations still 
needed. 



35 



Intl. J. Microbiol. Res., 1 (1): 33-36, 2010 



In conclusion, nanosilver solution has a powerful 
antimicrobial activity against multi drug resistant clinical 
Ggram positive and Gram negative bacteria and further 
studies still required. 

REFERENCES 

1. Darouiche, R.O., 1999. Anti-infective efficacy of 
silver-coated medical prostheses. Clin. Infect. Dis., 
29(6): 1371-7. 

2. Furno, F., K.S. Morley, B. Wong, B.L. Sharp, 
PL. Arnold, S.M. Howdle, R. Bayston, P.D. Brown, 
P.D. Winship and H.J. Reid, 2004. Silver 
nanoparticles and polymeric medical devices: a 
new approach to prevention of infection? J. 
Antimicrobial Chemotherapy, 54(6): 1019-1024. 

3. Klasen, H.J., 2000. Historical review of the use of 
silver in the treatment of burns. I. Early uses. 
Burns, 26(2): 117-30. 

4. Lansdown, A.B., 2002. Silver. I: Its antibacterial 
properties and mechanism of action. J. Wound Care, 
11(4): 125-30. 

5. Fox, C.L., 1968. Silver sulfadiazine~a new topical 
therapy for Pseudomonas in burns. Therapy of 
Pseudomonas infection in burns. Arch Surg, 
96(2): 184-8. 

6. Ip, M., S.L. Lui, V.K. Poon, I. Lung and A. Burd, 2006. 
Antimicrobial activities of silver dressings: an 
in vitro comparison. J. Med. Microbia, 55(Ptl): 59-63. 

7. Brown, M.R. and RA. Anderson, 1968. The 
bactericidal effect of silver ions on Pseudomonas 
aeruginosa. J. Pharm. Pharmacol., 20: Suppl:lS+. 

8. Sondi, I. and B. Salopek-Sondi, 2004. Silver 
nanoparticles as antimicrobial agent: a case study 
on E. coli as a model for Gram-negative bacteria. J. 
Colloid Interface Sci., 275(1): 177-182. 

9. Elechiguerra, J.L., J.L. Burt, J.R. Morones, 
A. Camacho-Bragado, X. Gao, H.H. Lara and 
M.J. Yacaman, 2005. Interaction of silver 
nanoparticles with HIV- 1. J. Nanobiotechnol., 29: 3-6. 

10. McDonnell, G. and A.D. Russell, 1999. Antiseptics 
and disinfectants: activity, action and resistance. 
Clin. Microbiol. Rev., 12(1): 147-79. 



1 1 . Wells, T.N., P. Scully, G. Paravicini, A.E. Proudfoot 
and MA. Payton, 1995. Mechanism of irreversible 
inactivation of phosphomannose isomerases by 
silver ions and flamazine. Biochemistry, 
34(24): 7896-903. 

12. Tien, D.C, C.Y. Liao, J.C Huang, K.H. Tseng, 
J.K. Lung, T.T. Tsun, W.S. Kao, T.H. Tsai, 
T.W. Cheng, B.S. Yu, H.M. Lin and L. Stobinski, 
2008. Novel Technique for preparing a nano- silver 
water suspension by the arc dischargemethod. Rev. 
Adv. Mater, 18: 750-756. 

13. Bauer, A.W., W.M. Ki, J.C. Sherris and M. Turck , 
1966. Antibiotic susceptibility testing by a 
standardized single disk method. Am. J.Clin. Pathol., 
45(4): 493-6. 

14. Bryaskova, R., D. Pencheva, M. Kyulavska, 
D. Bozukova, A. Debuigne and C. Detrembleur, 2009. 
Antibacterial activity of poly (vinyl alcohol)-b- 
poly(acrylonitrile) based micelles loaded with silver 
nanoparticles". J. Colloid Interface Sci. 2010 Apr, 15; 
344(2): 424-8. Epub 2009 Dec 28. 

15. Bragg, P.D. and D.J. Rainnie, 1974. The effect of 
silver ions on the respiratory chain of Escherichia 
coli. Can. J. Microbiol., 20(6): 883-9. 

16. Batarseh, K.I., 2004. Anomaly and correlation of 
killing in the therapeutic properties of silver (I) 
chelation with glutamic and tartaric acids. J. 
Antimicrobial Chemotherapy, 54(2): 546-8. 

1 7 . Richards, R.M., HA. Odelola and B. Anderson, 1 984. 
References and further reading may be available 
for this article. To view references and further 
reading you must this arctic, 1984. Effect of silver 
on whole cells and spheroplasts of a silver 
resistant Pseudomonas aeruginosa. Microbes, 
39(157-158): 151-7. 

18. Russell, AD. and W.B. Hugo, 1994. Antimicrobial 
activity and action of silver. Prog. Med. Chem., 
31: 351-70. 

19. Matsumura, Y., K. Yoshikata, S.I. Kunisaki and 
T. Tsuschido, 2003. Mode of Bactericidal Action of 
Silver Zeolite and Its Comparison with that of Silver 
Nitrate, App Env Micro., 69(7): 4278-4281 . 



36